On our screens:Stocks with no debtQuality compoundersLow-volatility growth stocksQuality at a reasonable price
The financials
STERIS plc by the numbers
STERIS plc (STE) reported revenue of $1.59B in Q4 2026 (quarter ended Mar 31, 2026), up 7.3% from the same quarter a year earlier. That came with a gross margin of 44% and net income of $220M (14% of revenue). For the full year FY2026, revenue was $5.94B (+8.7% year on year) and net income $782M. Its largest segment in Jun 2026 was Healthcare at $1.05B, 70% of the disclosed total, well ahead of Applied Sterilization Technologies at 20%.
| Income statement | Q4 2026 | Q4 2025 | Change |
|---|---|---|---|
| Revenue | $1.59B | $1.48B | +7.3% |
| Gross profit | $697M | $641M | +8.7% |
| Operating income | $317M | $216M | +47% |
| Net income | $220M | $146M | +51% |
| Diluted EPS | $2.24 | $1.47 | +52% |
| Operating | Revenue | Share |
|---|---|---|
| Healthcare | $1.05B | 70% |
| Applied Sterilization Technologies | $298M | 20% |
| Life Science | $147M | 9.8% |
Business Segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Jun 2026Total $1.49B (+416%)
Life Science grew +8.5% year on yearApplied Sterilization Technologies +5.8% year on year
Segment Latestquarter on quarteryear on year
- Healthcare$1.05B$1.05BQoQ -year on year +7.6%-+7.6%
- Applied Sterilization Technologies$297.6M$297.6MQoQ +2.9%year on year +5.8%+2.9%+5.8%
- Life Science$146.7M$146.7MQoQ -year on year +8.5%-+8.5%